Michele Tana, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone628-206-4095
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeA.B.2000Classics
    Harvard UniversityM.D.2005Medical Schoool
    Duke UniversityM.H.S.2016Clinical Research
    Stanford UniversityInternal Medicine2008School of Medicine
    California Pacific Medical CenterGastroenterology2011Department of Medicine
    National Institutes of HealthHepatology2013NIDDK
    University of California, San Francisco, CA2020Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Michele Tana grew up in Northern Virginia, studied the Classics at Harvard College, and attended Harvard Medical School. She trained in internal medicine at Stanford University Hospital and Clinics and gastroenterology at California Pacific Medical Center. She was a hepatology fellow at the National Institutes of Health in the National Institute of Diabetes and Digestive and Kidney Diseases and earned a masters degree in clinical research from Duke University.
    Dr. Tana joined the UCSF faculty in 2013. She serves the vulnerable patient population at Zuckerberg San Francisco General Hospital and investigates health equity in autoimmune hepatitis. She collaborates with researchers across disciplines to apply state-of-the-art science and technology to liver diseases.

    Collapse ORNG Applications 
    Collapse Collaboration Interests
    Collapse Student Projects

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLoS One. 2022; 17(3):e0264307. Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS. PMID: 35312680; PMCID: PMC8936448.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. 2022 01; 75(1):5-12. Wang CW, Grab J, Tana MM, Irani RA, Sarkar M. PMID: 34455632; PMCID: PMC8688263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):382-392. Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. PMID: 34853019; PMCID: PMC8825691.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Thinking Ahead: Advance Care Planning for Patients With Cirrhosis. Clin Liver Dis (Hoboken). 2022 Jan; 19(1):7-11. Deng LX, Tana MM, Lai JC. PMID: 35106142; PMCID: PMC8785911.
      View in: PubMed   Mentions:
    5. We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases. Hepatology. 2021 11; 74(5):2876-2887. Lee BT, Tana MM, Kahn JA, Dara L. PMID: 34056734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response. Hepatol Commun. 2021 11; 5(11):1888-1900. Gara N, Tana MM, Kattapuram M, Auh S, Sullivan L, Fryzek N, Walter M, Umarova R, Zhao X, Cloherty G, Doo E, Heller T, Liang TJ, Ghany MG. PMID: 34558806; PMCID: PMC8557321.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    7. Texture features from computed tomography correlate with markers of severity in acute alcohol-associated hepatitis. Sci Rep. 2020 10 21; 10(1):17980. Tana MM, McCoy D, Lee B, Patel R, Lin J, Ohliger MA. PMID: 33087739; PMCID: PMC7578052.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Obesity and metabolic outcomes in a safety-net health system. Biodemography Soc Biol. 2020 Jul-Sep; 65(3):257-267. Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M. PMID: 32727275; PMCID: PMC7398271.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):79-87. Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S. PMID: 31719066; PMCID: PMC6986425.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample. Dig Dis Sci. 2020 02; 65(2):406-415. Galoosian A, Hanlon C, Tana M, Cheung R, Wong RJ. PMID: 31489564.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. The Spectrum of Hepatic Involvement in Patients With Telomere Disease. Hepatology. 2019 06; 69(6):2579-2585. Kapuria D, Ben-Yakov G, Ortolano R, Cho MH, Kalchiem-Dekel O, Takyar V, Lingala S, Gara N, Tana M, Kim YJ, Kleiner DE, Young NS, Townsley DM, Koh C, Heller T. PMID: 30791107; PMCID: PMC7440774.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    12. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity. 2018 08; 51(5):258-264. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. PMID: 29890851; PMCID: PMC6311708.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Am J Gastroenterol. 2018 02; 113(2):243-253. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. PMID: 29380822; PMCID: PMC6522224.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    14. Imaging Manifestations of Peptic Ulcer Disease on Computed Tomography. Semin Ultrasound CT MR. 2018 Apr; 39(2):183-192. Baghdanian AH, Baghdanian AH, Baghdanian AA, Puppala S, Tana M, Ohliger MA. PMID: 29571554.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms. Fatigue: Biomedicine, Health & Behavior. 2017; 6(1):5-19. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. View Publication.
    16. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms. Fatigue. 2018; 6(1):5-19. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. PMID: 30546968; PMCID: PMC6287634.
      View in: PubMed   Mentions: 1  
    17. Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue? Clin Gastroenterol Hepatol. 2018 01; 16(1):16-18. Tana MM, Muir AJ. PMID: 28694131.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clin Chim Acta. 2016 Dec 01; 463:1-3. van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL. PMID: 27732874.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    19. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer. 2016 08 15; 122(16):2512-23. Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ. PMID: 27195481.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    20. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol. 2016 May-Jun; 50(5):423-30. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. PMID: 26583267.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    21. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. Am J Clin Pathol. 2015 Oct; 144(4):601-6. Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. PMID: 26386081; PMCID: PMC5092169.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015 May; 135(5):823-8. Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. PMID: 25728497; PMCID: PMC4414791.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    23. Autoantibodies in hepatitis C: red flag or bystander effect? J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):243. Tana MM, Heller T. PMID: 23443062; PMCID: PMC3584299.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Hepatitis B virus treatment: Management of antiviral drug resistance. Clin Liver Dis (Hoboken). 2013 Feb; 2(1):24-28. Tana MM, Ghany MG. PMID: 30992816; PMCID: PMC6448614.
      View in: PubMed   Mentions:
    25. Scar undone: long-term therapy of hepatitis B. Lancet. 2013 Feb 09; 381(9865):433-4. Tana MM, Hoofnagle JH. PMID: 23234726.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    Michele's Networks
    Concepts (132)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California